{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:28:31Z","timestamp":1793896111495,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T00:00:00Z","timestamp":1697846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22K17184"],"award-info":[{"award-number":["JP22K17184"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dental treatments often cause anxiety, fear, and stress in patients. Intravenous sedation is widely used to alleviate these concerns, and various agents are employed for sedation. However, it is important to find safer and more effective sedation agents, considering the adverse effects associated with current agents. This study aimed to investigate the efficacy and safety of remimazolam besilate (hereinafter called \u201cremimazolam\u201d) and to determine the optimal dosages for sedation in outpatients undergoing dental procedures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-one outpatients aged 18\u201365 years scheduled for impacted third molar extraction were included in the study. Remimazolam was administered as a single dose of 0.05\u00a0mg\/kg followed by a continuous infusion at a rate of 0.35\u00a0mg\/kg\/h, with the infusion rate adjusted to maintain a sedation level at a Modified Observer\u2019s Assessment of Alertness\/Sedation (MOAA\/S) score of 2\u20134. The primary endpoint was the sedation success rate with remimazolam monotherapy, and the secondary endpoints included induction time, recovery time, time until discharge, remimazolam dose, respiratory and circulatory dynamics, and frequency of adverse events.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The sedation success rate with remimazolam monotherapy was 100%. The remimazolam induction dose was 0.08 (0.07\u20130.09) mg\/kg, and the anesthesia induction time was 3.2 (2.6\u20133.9) min. The mean infusion rate of remimazolam during the procedure was 0.40 (0.38\u20130.42) mg\/kg\/h. The time from the end of remimazolam administration to awakening was 8.0 (6.7\u20139.3) min, and the time from the end of remimazolam administration to discharge was 14.0 (12.5\u201315.5) min. There were no significant respiratory or circulatory effects requiring intervention during sedation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Continuous intravenous administration of remimazolam can achieve optimal sedation levels without significantly affecting respiratory or circulatory dynamics. The study also provided guidance on the appropriate dosage of remimazolam for achieving moderate sedation during dental procedures. Additionally, the study findings suggest that electroencephalogram monitoring can be a reliable indicator of the level of sedation during dental procedural sedation with remimazolam.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>The study was registered in the Japan Registry of Clinical Trials (No. jRCTs061220052) on 30\/08\/2022.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12903-023-03538-2","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T11:02:07Z","timestamp":1697886127000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and safety of remimazolam besilate for sedation in outpatients undergoing impacted third molar extraction: a prospective exploratory study"],"prefix":"10.1186","volume":"23","author":[{"given":"Kana","family":"Oue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamayo","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisanobu","family":"Kamio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Utaka","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serika","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Imado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akari","family":"Mukai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyuki","family":"Sakuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonao","family":"Aikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,21]]},"reference":[{"key":"3538_CR1","doi-asserted-by":"publisher","first-page":"103632","DOI":"10.1016\/j.jdent.2021.103632","volume":"108","author":"ER Silveira","year":"2021","unstructured":"Silveira ER, Cademartori MG, Schuch HS, Armfield JA, Demarco FF. Estimated prevalence of dental fear in adults: a systematic review and meta-analysis. J Dent. 2021;108:103632.","journal-title":"J Dent"},{"key":"3538_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2334\/josnusd.51.245","volume":"51","author":"S Kumar","year":"2009","unstructured":"Kumar S, Bhargav P, Patel A, Bhati M, Balasubramanyam G, Duraiswamy P, et al. Does dental anxiety influence oral health-related quality of life? Observations from a cross-sectional study among adults in Udaipur district, India. J Oral Sci. 2009;51:245\u201354.","journal-title":"J Oral Sci"},{"key":"3538_CR3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.12998\/wjcc.v2.i11.642","volume":"2","author":"AE Carter","year":"2014","unstructured":"Carter AE, Carter G, Boschen M, AlShwaimi E, George R. Pathways of fear and anxiety in dentistry: a review. World J Clin Cases. 2014;2:642\u201353.","journal-title":"World J Clin Cases"},{"key":"3538_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.cden.2015.11.009","volume":"60","author":"JH Southerland","year":"2016","unstructured":"Southerland JH, Brown LR. Conscious intravenous sedation in dentistry: a review of current therapy. Dent Clin North Am. 2016;60:309\u201346.","journal-title":"Dent Clin North Am"},{"key":"3538_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10266-022-00711-x","volume":"111","author":"C Lu","year":"2023","unstructured":"Lu C, Zhang YY, Xiang B, Peng SM, Gu M, Wong HM. Management of fear and anxiety in dental treatments: a systematic review and meta-analysis of randomized controlled trials. Odontology. 2023;111:20\u201332.","journal-title":"Odontology"},{"key":"3538_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34:543\u201353.","journal-title":"J Anesth"},{"key":"3538_CR7","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1213\/ANE.0b013e3182942954","volume":"117","author":"T Schnider","year":"2013","unstructured":"Schnider T, Minto C. Context sensitive decrement times of remimazolam. Anesth Analg. 2013;117:285.","journal-title":"Anesth Analg"},{"key":"3538_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1097\/ALN.0000000000003102","volume":"132","author":"A Eisenried","year":"2020","unstructured":"Eisenried A, Sch\u00fcttler J, Lerch M, Ihmsen H, Jeleazcov C. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part II. Pharmacodynamics of electroencephalogram effects. Anesthesiology. 2020;132:652\u201366.","journal-title":"Anesthesiology"},{"key":"3538_CR9","doi-asserted-by":"publisher","first-page":"209","DOI":"10.2334\/josnusd.21-0051","volume":"63","author":"S Oka","year":"2021","unstructured":"Oka S, Satomi H, Sekino R, Taguchi K, Kajiwara M, Oi Y, et al. Sedation outcomes for remimazolam, a new benzodiazepine. J Oral Sci. 2021;63:209\u201311.","journal-title":"J Oral Sci"},{"key":"3538_CR10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/LBR.0000000000000784","volume":"29","author":"NJ Pastis","year":"2022","unstructured":"Pastis NJ, Hill NT, Yarmus LB, Schippers F, Imre M, Sohngen W, et al. Correlation of vital signs and depth of sedation by Modified Observer\u2019s Assessment of Alertness and Sedation (MOAA\/S) scale in bronchoscopy. J Bronchol Interv Pulmonol. 2022;29:54\u201361.","journal-title":"J Bronchol Interv Pulmonol"},{"key":"3538_CR11","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00004714-199008000-00003","volume":"10","author":"DA Chernik","year":"1990","unstructured":"Chernik DA, Gillings D, Laine H, Hendler J, Silver JM, Davidson AB, et al. Validity and reliability of the Observer\u2019s Assessment of Alertness\/Sedation scale: study with intravenous midazolam. J Clin Psychopharmacol. 1990;10:244\u201351.","journal-title":"J Clin Psychopharmacol"},{"key":"3538_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1053\/joms.2001.23366","volume":"59","author":"NA Sandler","year":"2001","unstructured":"Sandler NA, Hodges J, Sabino M. Assessment of recovery in patients undergoing intravenous conscious sedation using bispectral analysis. J Oral Maxillofac Surg. 2001;59:603\u201312.","journal-title":"J Oral Maxillofac Surg"},{"key":"3538_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00540-022-03099-8","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, Hagihira S. Equilibration rate constant, ke0, to determine effect-site concentration for the Masui remimazolam population pharmacokinetic model in general anesthesia patients. J Anesth. 2022;36:757\u201362.","journal-title":"J Anesth"},{"key":"3538_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00540-022-03079-y","volume":"36","author":"K Masui","year":"2022","unstructured":"Masui K, Stohr T, Pesic M, Tonai T. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice. J Anesth. 2022;36:493\u2013505.","journal-title":"J Anesth"},{"key":"3538_CR15","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/j.1365-2044.2007.05230.x","volume":"62","author":"CW Cheung","year":"2007","unstructured":"Cheung CW, Ying CL, Chiu WK, Wong GT, Ng KF, Irwin MG. A comparison of dexmedetomidine and midazolam for sedation in third molar Surgery. Anaesthesia. 2007;62:1132\u20138.","journal-title":"Anaesthesia"},{"key":"3538_CR16","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1159\/000362797","volume":"88","author":"P Grendelmeier","year":"2014","unstructured":"Grendelmeier P, Tamm M, Jahn K, Pflimlin E, Stolz D. Propofol versus midazolam in medical thoracoscopy: a randomized, noninferiority trial. Respiration. 2014;88:126\u201336.","journal-title":"Respiration"},{"key":"3538_CR17","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1016\/0006-2952(88)90622-3","volume":"37","author":"G Fabre","year":"1988","unstructured":"Fabre G, Rahmani R, Placidi M, Combalbert J, Covo J, Cano JP, et al. Characterization of midazolam metabolism using human hepatic microsomal fractions and hepatocytes in suspension obtained by perfusing whole human livers. Biochem Pharmacol. 1988;37:4389\u201397.","journal-title":"Biochem Pharmacol"},{"key":"3538_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.4253\/wjge.v12.i8.241","volume":"12","author":"JAL Guacho","year":"2020","unstructured":"Guacho JAL, de Moura DTH, Ribeiro IB, da Ponte Neto AM, Singh S, Tucci MGB, et al. Propofol vs midazolam sedation for elective endoscopy in patients with Cirrhosis: a systematic review and meta-analysis of randomized controlled trials. World J Gastrointest Endosc. 2020;12:241\u201355.","journal-title":"World J Gastrointest Endosc"},{"key":"3538_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.resinv.2021.11.010","volume":"60","author":"T Matsumoto","year":"2022","unstructured":"Matsumoto T, Kaneko A, Fujiki T, Kusakabe Y, Noda A, Tanaka A, et al. Prevalence and characteristics of disinhibition during bronchoscopy with midazolam. Respir Investig. 2022;60:345\u201354.","journal-title":"Respir Investig"},{"key":"3538_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0952-8180(96)00214-0","volume":"9","author":"A Gupta","year":"1997","unstructured":"Gupta A, Lind S, Eklund A, Lennmarken C. The effects of midazolam and flumazenil on psychomotor function. J Clin Anesth. 1997;9:21\u20135.","journal-title":"J Clin Anesth"},{"key":"3538_CR21","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/den.12678","volume":"28","author":"K Kashiwagi","year":"2016","unstructured":"Kashiwagi K, Hosoe N, Takahashi K, Nishino H, Miyachi H, Kudo SE, et al. Prospective, randomized, placebo-controlled trial evaluating the efficacy and safety of propofol sedation by anesthesiologists and gastroenterologist-led teams using computer-assisted personalized sedation during upper and lower gastrointestinal endoscopy. Dig Endosc. 2016;28:657\u201364.","journal-title":"Dig Endosc"},{"key":"3538_CR22","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00540-023-03177-5","volume":"37","author":"T Hara","year":"2023","unstructured":"Hara T, Ozawa A, Shibutani K, Tsujino K, Miyauchi Y, Kawano T, et al. Practical guide for safe sedation. J Anesth. 2023;37:340\u201356.","journal-title":"J Anesth"},{"key":"3538_CR23","doi-asserted-by":"publisher","first-page":"d1110","DOI":"10.1136\/bmj.d1110","volume":"342","author":"L Jalota","year":"2011","unstructured":"Jalota L, Kalira V, George E, Shi YY, Hornuss C, Radke O, et al. Prevention of pain on injection of propofol: systematic review and meta-analysis. BMJ. 2011;342:d1110.","journal-title":"BMJ"},{"key":"3538_CR24","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s40265-015-0419-5","volume":"75","author":"GM Keating","year":"2015","unstructured":"Keating GM. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015;75:1119\u201330.","journal-title":"Drugs"},{"key":"3538_CR25","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/bja\/88.5.669","volume":"88","author":"RM Venn","year":"2002","unstructured":"Venn RM, Karol MD, Grounds RM. Pharmacokinetics of dexmedetomidine infusions for sedation of postoperative patients requiring intensive care. Br J Anaesth. 2002;88:669\u201375.","journal-title":"Br J Anaesth"},{"key":"3538_CR26","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.joms.2009.09.107","volume":"68","author":"L Makary","year":"2010","unstructured":"Makary L, Vornik V, Finn R, Lenkovsky F, McClelland AL, Thurmon J, et al. Prolonged recovery associated with dexmedetomidine when used as a sole sedative agent in office-based oral and maxillofacial Surgery procedures. J Oral Maxillofac Surg. 2010;68:386\u201391.","journal-title":"J Oral Maxillofac Surg"},{"key":"3538_CR27","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/ALN.0000000000003103","volume":"132","author":"J Sch\u00fcttler","year":"2020","unstructured":"Sch\u00fcttler J, Eisenried A, Lerch M, Fechner J, Jeleazcov C, Ihmsen H. Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. Pharmacokinetics and clinical pharmacodynamics. Anesthesiology. 2020;132:636\u201351.","journal-title":"Anesthesiology"},{"key":"3538_CR28","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115:274\u201383.","journal-title":"Anesth Analg"},{"key":"3538_CR29","doi-asserted-by":"publisher","first-page":"900723","DOI":"10.3389\/fphar.2022.900723","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Hu X, Bai N, Li L, Zhang M, Cheng Z, et al. Safety and efficacy of remimazolam besylate in patients undergoing colonoscopy: a multicentre, single-blind, randomized, controlled, phase III trial. Front Pharmacol. 2022;13:900723.","journal-title":"Front Pharmacol"},{"key":"3538_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/jcpt.13525","volume":"47","author":"S Zhang","year":"2022","unstructured":"Zhang S, Wang J, Ran R, Peng Y, Xiao Y. Efficacy and safety of remimazolam tosylate in hysteroscopy: a randomized, single-blind, parallel controlled trial. J Clin Pharm Ther. 2022;47:55\u201360.","journal-title":"J Clin Pharm Ther"},{"key":"3538_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s40122-023-00483-4","volume":"12","author":"S Fan","year":"2023","unstructured":"Fan S, Zhu Y, Sui C, Li Q, Jiang W, Zhang L. Remimazolam compared to propofol during hysteroscopy: a safety and efficacy analysis. Pain Ther. 2023;12:695\u2013706.","journal-title":"Pain Ther"},{"key":"3538_CR32","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12871-022-01713-6","volume":"22","author":"J Guo","year":"2022","unstructured":"Guo J, Qian Y, Zhang X, Han S, Shi Q, Xu J. Remimazolam tosilate compared with propofol for gastrointestinal endoscopy in elderly patients: a prospective, randomized and controlled study. BMC Anesthesiol. 2022;22:180.","journal-title":"BMC Anesthesiol"},{"key":"3538_CR33","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.gie.2018.04.2351","volume":"88","author":"DK Rex","year":"2018","unstructured":"Rex DK, Bhandari R, Desta T, DeMicco MP, Schaeffer C, Etzkorn K, et al. A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy. Gastrointest Endosc. 2018;88:427\u201337e6.","journal-title":"Gastrointest Endosc"},{"key":"3538_CR34","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.chest.2018.09.015","volume":"155","author":"NJ Pastis","year":"2019","unstructured":"Pastis NJ, Yarmus LB, Schippers F, Ostroff R, Chen A, Akulian J, et al. Safety and efficacy of remimazolam compared with placebo and midazolam for moderate sedation during bronchoscopy. Chest. 2019;155:137\u201346.","journal-title":"Chest"},{"key":"3538_CR35","doi-asserted-by":"publisher","first-page":"950564","DOI":"10.3389\/fmed.2022.950564","volume":"9","author":"N Zhao","year":"2022","unstructured":"Zhao N, Zeng J, Fan L, Wang J, Zhang C, Zou S, et al. Moderate sedation by total intravenous remimazolam-alfentanil vs. propofol-alfentanil for third molar extraction: a prospective randomized controlled trial. Front Med (Lausanne). 2022;9:950564.","journal-title":"Front Med (Lausanne)"},{"key":"3538_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.joms.2022.09.008","volume":"81","author":"Z Guo","year":"2023","unstructured":"Guo Z, Wang X, Wang L, Liu Y, Yang X. Can remimazolam be a new sedative option for outpatients undergoing ambulatory oral and maxillofacial Surgery? J Oral Maxillofac Surg. 2023;81:8\u201316.","journal-title":"J Oral Maxillofac Surg"},{"key":"3538_CR37","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.joms.2023.02.001","volume":"81","author":"X Li","year":"2023","unstructured":"Li X, Tian M, Deng Y, She T, Li K. Advantages of sedation with remimazolam compared to midazolam for the removal of impacted tooth in patients with dental anxiety. J Oral Maxillofac Surg. 2023;81:536\u201345.","journal-title":"J Oral Maxillofac Surg"},{"key":"3538_CR38","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.2147\/DDDT.S391147","volume":"16","author":"B Hu","year":"2022","unstructured":"Hu B, Jiang K, Shi W, Xiao S, Zhang S, Zhang Y, et al. Effect of remimazolam tosilate on respiratory depression in elderly patients undergoing gastroscopy: a multicentered, prospective, and randomized study. Drug Des Devel Ther. 2022;16:4151\u20139.","journal-title":"Drug Des Devel Ther"},{"key":"3538_CR39","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/978-3-540-74806-9_16","volume":"182","author":"KT Olkkola","year":"2008","unstructured":"Olkkola KT, Ahonen J. Midazolam and other benzodiazepines. Handb Exp Pharmacol. 2008;182:335\u201360.","journal-title":"Handb Exp Pharmacol"},{"key":"3538_CR40","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1097\/00000542-200606000-00009","volume":"104","author":"JR Norton","year":"2006","unstructured":"Norton JR, Ward DS, Karan S, Voter WA, Palmer L, Varlese A, et al. Differences between midazolam and propofol sedation on upper airway collapsibility using dynamic negative airway pressure. Anesthesiology. 2006;104:1155\u201364.","journal-title":"Anesthesiology"},{"key":"3538_CR41","doi-asserted-by":"publisher","first-page":"e0171627","DOI":"10.1371\/journal.pone.0171627","volume":"12","author":"R Masuda","year":"2017","unstructured":"Masuda R, Nonaka M, Nishimura A, Gotoh K, Oka S, Iijima T. Optimal and safe standard doses of midazolam and propofol to achieve patient and doctor satisfaction with dental treatment: a prospective cohort study. PLoS ONE. 2017;12:e0171627.","journal-title":"PLoS ONE"},{"key":"3538_CR42","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/jpm13030461","volume":"13","author":"T Ito","year":"2023","unstructured":"Ito T, Utsumi N, Baba Y, Matsumura T, Wakita R, Maeda S. Considerations for satisfactory sedation during dental implant Surgery. J Pers Med. 2023;13:461.","journal-title":"J Pers Med"},{"key":"3538_CR43","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bjoms.2012.08.013","volume":"51","author":"TW Fan","year":"2013","unstructured":"Fan TW, Ti LK, Islam I. Comparison of dexmedetomidine and midazolam for conscious sedation in dental Surgery monitored by bispectral index. Br J Oral Maxillofac Surg. 2013;51:428\u201333.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"3538_CR44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2344\/0003-3006-63.2.67","volume":"63","author":"S Maeda","year":"2016","unstructured":"Maeda S, Tomoyasu Y, Higuchi H, Honda Y, Ishii-Maruhama M, Miyawaki T. Female patients require a higher propofol infusion rate for sedation. Anesth Prog. 2016;63:67\u201370.","journal-title":"Anesth Prog"},{"key":"3538_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.jclinane.2011.04.008","volume":"23","author":"M Sakaguchi","year":"2011","unstructured":"Sakaguchi M, Higuchi H, Maeda S, Miyawaki T. Dental sedation for patients with intellectual disability: a prospective study of manual control versus Bispectral Index-guided target-controlled infusion of propofol. J Clin Anesth. 2011;23:636\u201342.","journal-title":"J Clin Anesth"},{"key":"3538_CR46","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.4317\/medoral.22884","volume":"25","author":"S P\u00e9rez-Garc\u00eda","year":"2020","unstructured":"P\u00e9rez-Garc\u00eda S, Lozano-Carrascal N, Ruiz-Roca JA, L\u00f3pez-Jornet P, Gargallo-Albiol J. Evaluation of endovenous sedation using BIS monitoring in dentistry. A systematic review. Med Oral Patol Oral Cir Bucal. 2020;25:e439\u2013e48.","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"3538_CR47","first-page":"200","volume":"24","author":"TD Caputo","year":"2011","unstructured":"Caputo TD, Ramsay MA, Rossmann JA, Beach MM, Griffiths GR, Meyrat B, et al. Evaluation of the SEDline to improve the safety and efficiency of conscious sedation. Proc (Bayl Univ Med Cent). 2011;24:200\u20134.","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"3538_CR48","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491\u2013501.","journal-title":"J Anesth"},{"key":"3538_CR49","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s00540-021-03030-7","volume":"36","author":"K Shirozu","year":"2022","unstructured":"Shirozu K, Nobukuni K, Tsumura S, Imura K, Nakashima K, Takamori S, et al. Neurological sedative indicators during general anesthesia with remimazolam. J Anesth. 2022;36:194\u2013200.","journal-title":"J Anesth"},{"key":"3538_CR50","first-page":"235","volume":"19","author":"KH Lee","year":"2015","unstructured":"Lee KH, Kim YH, Sung YJ, Oh MK. The patient State Index is well balanced for propofol sedation. Hippokratia. 2015;19:235\u20138.","journal-title":"Hippokratia"},{"key":"3538_CR51","doi-asserted-by":"publisher","first-page":"4675","DOI":"10.2147\/DDDT.S339535","volume":"15","author":"X Liu","year":"2021","unstructured":"Liu X, Ding B, Shi F, Zhang Y, Liu L, Sha Y, et al. The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy: a prospective, randomized, single-blind, non-inferiority trial. Drug Des Devel Ther. 2021;15:4675\u201385.","journal-title":"Drug Des Devel Ther"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-023-03538-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-023-03538-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T16:08:06Z","timestamp":1700410086000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-023-03538-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3538"],"URL":"https:\/\/doi.org\/10.1186\/s12903-023-03538-2","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,21]]},"assertion":[{"value":"24 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved by the Hiroshima University Certified Review Board (approval number: CRB2022-0001), and the ethical aspects of the trial were explained to the participants. Following the Declaration of Helsinki and its guidelines, informed consent was obtained from all patients before participation. This trial was registered in the Japan Registry of Clinical Trials (jRCTs061220052) on 30\/8\/2022.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"774"}}